Contera Pharma A/S

Contera Pharma A/S develops biotechnology solutions for neurological disorders. The Company focuses on RNA-based drug discovery, precision medicine, and clinical development of therapies for Parkinson's disease and other CNS conditions. Contera Pharma A/S serves patients in the United States, Europe, and Denmark.